Why Are Lipids Not Predictive of Cardiovascular Death in the Dialysis Patient?

Mineral and Electrolyte Metabolism

Volumn 22, Issue 1-3, 1996, Pages 9-12

  Ritz, Eberhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Atherosclerosis; Cholesterol; Lipoprotein(a); Malnutrition; Nitric oxide

Indexed keywords

ARGININE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE;

BLOOD PRESSURE; CONFERENCE PAPER; DIABETES MELLITUS; DIALYSIS; FATALITY; HEART ARREST; HEART INFARCTION; HUMAN; LIPID METABOLISM; MALNUTRITION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

APOLIPOPROTEINS B; ARGININE; ARTERIOSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; COMPARATIVE STUDY; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DIABETIC NEPHROPATHIES; HEART DISEASES; HUMAN; LIPOPROTEIN(A); LIPOPROTEINS, LDL CHOLESTEROL; NUTRITION DISORDERS; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; RISK ASSESSMENT; SURVIVAL RATE;

EID: 0029655751     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Lindner A, Charra B, Sherrard D, Scribner BM: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-444.
3. Combined Report on Regular Dialysis and Transplantation in Europe XXII, 1991. Nephrol Dial Transplant 1992;7(suppl 2):5-48.
4. Ritz E, Strumpf C, Katz F, Wing AJ, Quellhorst E: Hypertension and cardiovascular risk factors in hemodialyzed diabetic patients. Hypertension 1985;7(suppl II):II-118-II-124.
5. Ritz E, Wiecek A, Rambausek M: Cardiovascular death in patients with end-stage renal failure: Strategies for prevention. International Yearbook Nephrol Dial Transplant 1994;9(suppl):120-128.
6. Ritz E, Koch M: Hypertension as risk factor for renal patients. Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 1993;5(suppl 2):113-118.
7. Fliser D, Schweizer C, Ritz E: How many patients with renal insufficiency survive until end-stage renal failure? Nephrol Dial Transplant 1991;6:600.
8. Lippert J, Schwarzbeck A, Schneider P, Ritz E: Niereninsuffizienz infolge diabetischer Nephropathie: epidemiologische Dimension des Problems (abstract). 27. Arbeitsgemeinschaft Klinische Nephrologie, Zürich, September 1994.
9. Ritz E, Deppisch R, Nawroth P: Toxicity of uremia: Does it come of AGE? Nephrol Dial Transplant 1994;9:1-2.
10. Massy ZA, Chadefaux-Vekemans B, Chevalier A, Bader CA, Drüeke TB, Legendre C, Lacour B, Kamoun P, Kreis H: Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 1994;9:1103-1108.
11. Ritz E, Deppisch R, Stier E, Hänsch G: Atherogenesis and cardiac death: Are they related to dialysis procedure and biocompatibility? Nephrol Dial Transplant 1994;9(suppl 2):165-172.
12. Degoulet P, Legrain M, Reach J, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis: Report of the Diaphane collaborative study. Nephron 1982;31:103-110.
13. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G: Survival as an index of adequacy of dialysis. Kidney Int 1992;41:1286-1291.
14. Avram MM, Goldwasser P, Burrell DE, Antignani A, Fein PA, Mittman N: The uremic dyslipidemia: A cross-sectional and longitudinal study. Am J Kidney Dis 1992;10:324-335.
15. Goldwasser P, Mittman N, Antignani A: Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 1993;3:1613-1622.
16. Attman PO, Alaupovic P, Gustafson A: Serum apolipoprotein profile of patients with chronic renal failure. Kidney Int 1987;32:368-375.
17. Hörkko S, Savolainen MJ, Kervinen K, Kesäniemi YA: Carbamylation-induced alterations in low-density lipoprotein metabolism. Kidney Int 1992;41:1175-1181.
18. Dieplinger H, Lackner C, Kronenberg F: Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal diseases are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 1993;91:397-401.
19. Cressman MD, Heyka RJ, Paganini EP, O'Neil J, Skibinski CI, Hoff HF: Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992;86:475-482.
20. Wanner C, Bartens W, Walz G, Nauck M, Schollmeyer P.: Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients. Nephrol Dial Transplant 1995;10:75-81.
21. Tschöpe W, Koch M, Thomas B, Ritz E: Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis (results of a prospective study). Nephron 1993;64:354-358.
22. Ritz E, Vallance P, Nowicki M: The effect of malnutrition on cardiovascular mortality in dialysis patients: Is L-arginine the answer? Nephrol Dial Transplant 1994;9:129-130.
23. Vallance OP, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992;339:572-575.
24. Luik AJ, Struijk DG, Gladziwa U, v Olden RW, v Hooff JP, de Leeuw PW, Leunissen KML: Diurnal blood-pressure variations in haemodialysis and CAPD patients. Nephrol Dial Transplant 1994;9:1616-1621.
25. Raij L, Coffee K, Guerra J, Holmes D: Glomerular thrombosis in pregnancy: Role of the L-arginine nitric acid pathway. Kidney Int 1994;45:775.